TACE and/or HAIC Combined With Molecular-targeted Therapy and Immunotherapy for HCC

NCT07658833 · clinicaltrials.gov ↗

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

PROCEDURE: TACE (transarterial chemoembolization) combined with targeted/immunotherapy

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University